Recent investment activity

KANDO id: 133291

Corporate information

Official name
Remeditex Ventures Limited Liability Company
Registration country

Funding rounds

Actual initial investment stage

Investment activity status
Active investor

Selected investments

Displaying 1 - 2 of 2
Profile Country Date Funding
Bellicum Pharmaceuticals Inc Clinical stage company developing next generation therapeutic vaccines and other immunotherapeutic approaches for the treatment of cancer. N/A
Miragen Therapeutics Inc Ddeveloper of cardiovascular and muscle disease therapeutics based on microRNA biology. Series B Initial investment

Current team

Past employees

Selected Products / Customers

Financials